African Horse Sickness | EQUINE
Immunohistochemical demonstration of African horse sickness
viral antigen in formalin-fixed equine tissues. Veterinary pathology
1997;34:568-574.
11. Wohlsein P, Pohlenz JF, Salt JS, et al. Immunohistochemical
demonstration of African horse sickness viral antigen in tissues of
experimentally infected equines. Archives of virology Supplementum
1998;14:57-65.
12. Gomez-Villamandos JC, Sanchez C, Carrasco L, et al.
Pathogenesis of African horse sickness: ultrastructural study of
the capillaries in experimental infection. Journal of comparative
pathology 1999;121:101-116.
13. Laegreid WW, Stone-Marschat M, Skowronek A, et al. Infection
of endothelial cells by African Horse Sickness viruses. In: Walton
TE, Osburn BI, eds. Bluetongue, African Horse Sickness, and Telated
Orbiviruses. Boca Raton, Florida: CRC Press; 1992b:807-814.
14. Burrage TG, Laegreid WW. African horsesickness: pathogenesis
and immunity. Comparative immunology, microbiology and
infectious diseases 1994;17:275-285.
15. Brown CC, Meyer RF, Grubman MJ. Presence of African
horse sickness virus in equine tissues, as determined by in situ
hybridization. Veterinary pathology 1994;31:689-694.
16. Laegreid WW, Burrage TG, Stone-Marschat M, et al. Electron
microscopic evidence for endothelial infection by African
horsesickness virus. Veterinary pathology 1992;29:554-556.
17. Newsholme SJ. A morphological study of the lesions of African
horsesickness. The Onderstepoort journal of veterinary research
1983;50:7-24.
18. Carrasco L, Sanchez C, Gomez-Villamandos JC, et al. The role of
pulmonary intravascular macrophages in the pathogenesis of African
horse sickness. Journal of comparative pathology 1999;121:25-38.
19. Chay S, Woods WE, Rowse K, et al. The pharmacology of
furosemide in the horse. V. Pharmacokinetics and blood levels of
furosemide after intravenous administration. Drug metabolism and
disposition: the biological fate of chemicals 1983;11:226-231.
20. Johansson AM , Gardner SY, Levine JF, et al. Pharmacokinetics
and pharmacodynamics of furosemide after oral administration to
horses. Journal of veterinary internal medicine 2004;18:739-743.
21. Ettinger SJ, Benitz AM, Ericsson GF, et al. Effects of enalapril
maleate on survival of dogs with naturally acquired heart failure.
The Long-Term Investigation of Veterinary Enalapril (LIVE) Study
Group. Journal of the American Veterinary Medical Association
1998;213:1573-1577.
22. Funck-Brentano C, van Veldhuisen DJ, van de Ven LL, et al.
Influence of order and type of drug (bisoprolol vs. enalapril) on
outcome and adverse events in patients with chronic heart failure:
a post hoc analysis of the CIBIS-III trial. European journal of heart
failure 2011;13:765-772.
23. Afonso T, Giguere S, Rapoport G, et al. Pharmacodynamic
evaluation of 4 angiotensin-converting enzyme inhibitors in healthy
adult horses. Journal of veterinary internal medicine 2013;27:1185-
1192.
24. Afonso T, Giguere S, Brown SA, et al. Preliminary investigation
of orally administered benazepril in horses with left-sided valvular
regurgitation. Equine veterinary journal 2017.
25. Brumbaugh GW, Thomas WP, Enos LR, et al. A pharmacokinetic
study of digoxin in the horse. Journal of veterinary pharmacology and
therapeutics 1983;6:163-172.
26. Button C, Gross DR, Johnston JT, et al. Digoxin
pharmacokinetics, bioavailability, efficacy, and dosage regimens in
the horse. Am J Vet Res 1980;41:1388-1395.
27. Sweeney RW, Reef VB, Reimer JM. Pharmacokinetics of digoxin
administered to horses with congestive heart failure. Am J Vet Res
1993;54:1108-1111.
28. Boyle KL, Leech E. A review of the pharmacology and clinical
uses of pimobendan. Journal of veterinary emergency and critical
care (San Antonio, Tex : 2001) 2012;22:398-408.
29. Afonso T, Giguere S, Rapoport G, et al. Cardiovascular effects
of pimobendan in healthy mature horses. Equine veterinary journal
2016;48:352-356.
30. Nath LC, Anderson GA, Hinchcliff KW, et al. Serum cardiac
troponin I concentrations in horses with cardiac disease. Australian
veterinary journal 2012;90:351-357.
31. Schwarzwald CC, Hardy J, Buccellato M. High cardiac troponin
I serum concentration in a horse with multiform ventricular
tachycardia and myocardial necrosis. Journal of veterinary internal
medicine 2003;17:364-368.
32. Hewetson M, Shaik T. Myocardial dysfunction in horses with
AHS – should we be reconsidering our treatment strategy? In: South
African Equine Veterinary Association congress, Western Cape
Province, South Africa 2018;179.
33. Slack JA, McGuirk SM, Erb HN, et al. Biochemical markers of
cardiac injury in normal, surviving septic, or nonsurviving septic
neonatal foals. Journal of veterinary internal medicine 2005;19:577-
580.
34. Noszczyk-Nowak A. NT-pro-BNP and troponin I as predictors
of mortality in dogs with heart failure. Polish journal of veterinary
sciences 2011;14:551-556.
35. Yang HS, Hur M, Yi A, et al. Prognostic Role of High-sensitivity
Cardiac Troponin I and Soluble Suppression of Tumorigenicity-2
in Surgical Intensive Care Unit Patients Undergoing Non-cardiac
Surgery. Annals of laboratory medicine 2018;38:204-211.
• Volume 20 Issue 2 | July 2018 •
53